Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
durvalumab
×
Clear all
Filters
3
NCT04380636
2025-08-17
MK-7339-012
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
870 enrolled
NCT05298423
2025-08-01
KEYVIBE-006
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
611 enrolled